Fulcrum Therapeutics Inc
(NAS:FULC)
$
3.725
+0.035 (+0.95%)
Market Cap: 284.21 Mil
Enterprise Value: -29.36 Mil
PE Ratio: 0
PB Ratio: 0.91
GF Score: 44/100 Fulcrum Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 11, 2021 / 09:20PM GMT
Release Date Price:
$18.28
(-3.94%)
Judah C. Frommer;dit Suisse AG
CrÃ;Research Division - Senior Analyst
© -
Hi, everyone, and welcome to the final session of the 2021 Crédit Suisse Healthcare Conference. We're excited to have Bryan Stuart, President and CEO; and Chris Morabito, Chief Medical Officer, with us from Fulcrum. If anyone in the audience does have questions, you can certainly send them to me via email, [email protected], and I'll be sure to get those asked on your behalf. But we've got a long list here. So why don't we just jump in?
Questions & Answers
Judah C. Frommer;dit Suisse AG
CrÃ;Research Division - Senior Analyst
© -
I thought we could start with a little bit of background on the FulcrumSeek platform, and how it differentiates your discovery process versus competitors?
Bryan E. Stuart
Fulcrum Therapeutics, Inc. - President, CEO & Director
Yes. And Judah, thank you. We appreciate the time. We appreciate everybody tuning in. So Fulcrum was started about 6
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot